NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Head and neck cancer (squamous cell carcinoma) - cetuximab - NICE TAG TA172

Head and neck cancer (squamous cell carcinoma) - cetuximab - NICE TAG TA172

1.1 Cetuximab in combination with platinum-based chemotherapy is not recommended for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck.

1.2 People currently receiving cetuximab in combination with platinum-based chemotherapy for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck should have the option to continue treatment until they and their clinician consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA172

Site by Devopa
© Copyright 2019 NHS. All rights reserved.